• 대한방사선기술학회지:방사선기술과학
• /
• 제33권4호
• /
• pp.379-386
• /
• 2010

본 연구는 사이버나이프 Synchrony 호흡추적 장치를 이용하여 방사선 수술을 시행한 폐종양 환자 48명을 대상으로 전 치료기간 중 종양의 움직임과 방사선수술의 정확성을 평가하였다. 폐종양의 움직임은 종양이나 종양주변에 삽입된 금침의 좌표를 사이버나이프 영상유도 장치로 측정하였으며, 방사선수술의 정확성은 움직임 추적 컴퓨터(MTS)로 계산된 상관관계 오차로 평가하였다. 폐종양의 움직임은 두미방향으로 평균 $2.63{\pm}1.87\;mm$며, 좌우방향 $1.13{\pm}0.71\;mm$, 전후방향 $1.74{\pm}1.16\;mm$의 움직임을 보였으며, 회전 움직임 정도는 X축 $1.66{\pm}1.66^{\circ}$, Y축 $1.20{\pm}0.97^{\circ}$, Z축 $1.18{\pm}0.73^{\circ}$로 측정되었다. 직선 움직임의 벡터 값은 평균 $3.78{\pm}2.00\;mm$값을 나타냈다. 연구 결과에서 두미방향(p<0.001)과 전후방향(p<0.029), 3차원 벡터 값(p<0.002)들은 종양의 위치가 상부보다 하부의 움직임이 크게 나타나 통계적 유의성을 보였다. 사이버나이프 Synchrony 호흡추적 장치를 이용한 폐종양의 방사선 수술시 상관관계 오차는 전체 평균 $0.95{\pm}0.62\;mm$로 매우 정확한 조사로 종양의 움직임을 보상하여 방사선 수술이 이루어졌으며 그 유용성을 확인할 수 있었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권24호
• /
• pp.10591-10596
• /
• 2015

Background: Tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) has been reported to be associated with the development of various cancers. However, the role of TRAF6 in lung cancer remains unclear. Objective: To explore the expression and clinicopathological significance of TRAF6 protein in lung cancer tissues. Materials and Methods: Three hundred and sixty-five lung cancer samples and thirty normal lung tissues were constructed into 3 microarrays. The expression of TRAF6 protein was determined using immunohistochemistry (IHC). Furthermore, correlations between the expression of TRAF6 and clinicopathological parameters were investigated. Results: The expression of TRAF6 in total lung cancer tissues (365 cases), as well as in small cell lung cancer (SCLC, 26 cases) and non-small cell lung cancer (NSCLC, 339 cases) was significantly higher compared with that in normal lung tissues. The ROC curve showed that the area under curve of TRAF6 was 0.663 (95%CI 0.570~0.756) for lung cancer. The diagnostic sensitivity and specificity of TRAF6 were 52.6% and 80%, respectively. In addition, the expression of TRAF6 was correlated with clinical TNM stage, tumor size and lymph node metastasis in all lung cancers. Consistent correlations were also observed for NSCLCs. Conclusions: TRAF6 might be an oncogene and the expression of TRAF6 protein is related to the progression of lung cancer. Thus, TRAF6 might become a target for diagnosis and gene therapy for lung cancer patients.

• 한국임상수의학회지
• /
• 제32권6호
• /
• pp.530-535
• /
• 2015

11년령의 암컷 미니어처 푸들이 4개월의 혈흉으로 본 병원에 의뢰되었다. 신체검사에서, 비록 청진상에서 오른쪽 흉곽의 심음이 희미했으나 환축은 기민한 상태였다. 방사선 상에서 흉강은 흉수로 가득 차 있었다. 초음파 상에서는 양쪽 난소는 낭포성 변화가 관찰되었고 간에서 여러 개를 결절을 확인했다. 컴퓨터 단층 촬영에서 오른쪽 중간엽으로 들어가는 기관지의 허탈을 확인한 후에 거칠게 보였던 오른쪽 폐의 음영은 오른 중간엽 폐염전으로 진단되었다. 진단 5일후에 오른쪽 5번째 갈비뼈 사이로 접근하여 중간엽을 절제하였고 동시에 난소자궁적출술도 실시되었다. 병리조직학적 검사에서 양쪽 난소에서는 유두상 선암종이 나타났고, 중간엽에서는 난소에서 전이된 것으로 의심되는 선암종이 진단되었다. 환축은 2달동안 순조롭게 회복되었다. 그러나 4달 후에 환축은 호흡곤란으로 내원하였다. 방사선 상에서 흉수와 오른쪽 앞엽과 왼쪽 뒤엽이 허탈 되어 있었다. 그리고 흉수에서 전이로 의심되는 악성 상피종 세포가 관찰되었다. 보호자에게 항암 치료를 권해드렸으나 보류하셨고 환축은 퇴원하였다. 본 보고의 목적은 종양으로 인한 출혈성 흉수로 폐염전이 발생할 수 있는 드문 증례를 보고 하기 위함이다.

• 한국의학물리학회지:의학물리
• /
• 제20권3호
• /
• pp.174-179
• /
• 2009

사이버나이프 로봇 방사선 수술 시스템은 환자를 치료하는 동안 환자의 내부 기준 마커를 이용하여 종양의 위치를 실시간으로 추적 할 수 있는 시스템이다. 최근 폐종양 치료의 경우 기준 마커의 삽입 없이 폐종양의 밀도 차이를 이용하여 실시간 종양 추적을 할 수 있는 폐종양추적시스템이 개발되어 치료에 적용되고 있다. 최근 개발되어 국내 최초 도입된 폐종양 추적치료시스템의 위치 추적 정확도의 분석은 동적흉부 팬톰과 GafChromic film을 이용하였다. 폐종양추적시스템을 이용하여 종양의 위치 추적 정확도는 평균 오차 $0.85{\pm}0.22$ mm로 분석되었다. 기준마커 삽입 없이 폐종양추적시스템을 이용하여 폐종양 치료에 매우 유용한 것으로 판단되었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권1호
• /
• pp.29-32
• /
• 2014

Background and Objective: Lung cancer is one of the malignant diseases which most seriously threat humansurvival and development. This study aimed to assess osteopontin (OPN) expression in non-small cell lung cancer (NSCLC) and any relationship with clinicopathological features. Methods: Immunohistochemistry was used to determine OPN expression and microvascular density (MVD) in 120 cases of NSCLC also undergoing clinical assessment. Results: Moderately positive expression of OPN was found in 34.6% (41/120) and strong expression in 47.5% (57/120) of the NSCLCs; OPN expression in carcinomas was higher than in pericarcinoma tissues (P<0.05). While no obvious association was observed with NSCLC patient age, gender, maximum diameter of the tumor and pathological type, OPN expression was more commonly detected in poorly differentiated carcinoma tissue and lymph node metastasis as well as at advanced clinical stage (P<0.05); OPN expression in cancer tissue was positively correlated with MVD (r = 0.839, P = 0.000). Conclusion: OPN plays an important role in promoting tumor angiogenesis and progress of NSCLCs and has the possibility to become the new target for therapy.

• Nutritional Sciences
• /
• 제7권3호
• /
• pp.144-150
• /
• 2004

We have investigated the effect of calcium spirulan(Ca-SP) isolated from a blue-green alga Spirulina platensis, which is a sulfated polysaccharide chelating calcium and mainly composed of rhamnose and fructose, on invasion of both B16- BL6 melanoma cells, Colon 26 carcinoma and HT-1080 fibrosarcoma cells through reconstituted basement membrane (Matrigel). Ca-SP significantly inhibited the invasion of these tumor cells through Matrigel/fibronectin-coated filters in a concentration-dependent manner. Ca-SP also inhibited the haptotactic migration of tumor cells to laminin, but it had no inhibitory effect on tumor cell migration to fibronectin-coated filters. Ca-SP prevented the adhesion of B16-BL6 cells to Matrigel- and laminin-substrates but did not affect the adhesion to fibronectin. The pretreatment of tumor cells with Ca-SP inhibited the adhesion to laminin in a concentration-dependent fashion, while the pretreatment of laminin-substrates did not. Ca-SP had no effect on the production and activation of type IV collagenase in gelatin zymography. In contraset, Ca-SP significantly inhibited degradation of heparan sulfate by purified heparanase. The experimental lung metastasis was significantly reduced by co-injection of B16-BL6 cells with Ca-SP in a dose-dependent manner. Seven intermittent ⅰ.ⅴ. injection of 100$\mu\textrm{g}$ of Ca-SP caused a marked decrease of lung tumor colonization of B16-BL6 cells in a spontaneous lung metastasis model. These results suggest that Ca-SP, a novel sulfated polysaccharide, could reduce the lung colonization of B16-BL6 melanoma cells in experimental metastasis model, by inhibiting the tumor invasion of basement membrane Matrigel, probably through the prevention of the adhesion and migration of tumor cells to laminin-substrate and of the heparanase activity.

• Tuberculosis and Respiratory Diseases
• /
• 제44권6호
• /
• pp.1396-1402
• /
• 1997

저자 등은 폐 및 간의 다발성 결절을 보인 26세의 화학과 대학원생 남자 환자에서 경기관지 폐생검으로 진단된 유상피 세포성 혈관내피종 1예를 보고하는 바이다.

• The Korean Journal of Physiology and Pharmacology
• /
• 제23권6호
• /
• pp.529-537
• /
• 2019

Lung cancer is the most common cause of cancer deaths worldwide and several molecular signatures have been developed to predict survival in lung cancer. Increasing evidence suggests that proliferation and migration to promote tumor growth are associated with dysregulated ion channel expression. In this study, by analyzing high-throughput gene expression data, we identify the differentially expressed $K^+$ channel genes in lung cancer. In total, we prioritize ten dysregulated $K^+$ channel genes (5 up-regulated and 5 down-regulated genes, which were designated as K-10) in lung tumor tissue compared with normal tissue. A risk scoring system combined with the K-10 signature accurately predicts clinical outcome in lung cancer, which is independent of standard clinical and pathological prognostic factors including patient age, lymph node involvement, tumor size, and tumor grade. We further indicate that the K-10 potentially predicts clinical outcome in breast and colon cancers. Molecular signature discovered through $K^+$ gene expression profiling may serve as a novel biomarker to assess the risk in lung cancer.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권12호
• /
• pp.4891-4894
• /
• 2015

Background: To evaluate the value of combined detection of serum carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1), and carbohydrateantigen 125 (CA125) for the clinical diagnosis of nonsmall cell lung cancer (NSCLC). Materials and Methods: Serum CEA, CYFRA21-1 and CA125 were assessed in 140 patients with NSCLC, 90 patients with benign lung disease and 90 normal control subjects, and differences of expression were compared in each group, and joint effects of these tumor markers in the diagnosis of NSCLC were analyzed. Results: Serum CEA, CYFRA21-1 and CA125 in patients with NSCLC were significantly higher than those with benign lung disease and normal controls (P<0.05). The sensitivity of CEA, CYFRA21-1 and CA125 were 49.45%, 59.67%, and 44.87% respectively. As expected, combinations of these tumor markers improved their sensitivity for NSCLC. The combined detection of CEA + CYFRA21-1 was the most cost-effective combination which had higher sensitivity and specificity in NSCLC. Elevation of serum CEA and CYFRA21-1 was significantly associated with pathological types (P<0.05) and elevation of serum CEA, CYFRA21-1 and CA125 was significantly associated with TNM staging (P<0.05). Conclusions: Single measurement of CEA, CYFRA21-1 and CA125 is of diagnostic value in the diagnosis of lung cancer, and a joint detection of these three tumor markers, could greatly improve the sensitivity of diagnosis on NSCLC. Combined detection of CEA + CYFRA21-1 proved to be the most economic and practical strategy in diagnosis of NSCLC, which can be used to screen the high-risk group.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권2호
• /
• pp.611-616
• /
• 2014

Objectives: Dendritic cell (DC)-based tumor immunotherapy needs an immunogenic tumor associated antigen (TAA) and an effective approach for its presentation to lymphocytes. In this study we explored whether transduction of DCs with lentiviruses (LVs) expressing the human interleukin-12 gene could stimulate antigen-specific cytotoxic T cells (CTLs) against human lung cancer cells in vitro. Methods: Peripheral blood monocyte-derived DCs were transduced with a lentiviral vector encoding human IL-12 gene (LV-12). The anticipated target of the human IL-12 gene was detected by RT-PCR. The concentration of IL-12 in the culture supernatant of DCs was measured by ELISA.Transduction efficiencies and CD83 phenotypes of DCs were assessed by flow cytometry. DCs were pulsed with tumor antigen of lung cancer cells (DC+Ag) and transduced with LV-12 (DC-LV-12+Ag). Stimulation of T lymphocyte proliferation by DCs and activation of cytotoxic T-lymphocytes (CTL) stimulated by LV-12 transduced DCs pulsed with tumor antigen against A549 lung cancer cells were assessed with methyl thiazolyltetrazolium (MTT). Results: A recombinant lentivirus expressing the IL-12 gene was successfully constructed. DC transduced with LV-12 produced higher levels of IL-12 and expressed higher levels of CD83 than non-transduced. The DC modified by interleukin -12 gene and pulsed with tumor antigen demonstrated good stimulation of lymphocyte proliferation, induction of antigen-specific cytotoxic T lymphocytes and antitumor effects. Conclusions: Dendritic cells transduced with a lentivirus-mediated interleukin-12 gene have an enhanced ability to kill lung cancer cells through promoting T lymphocyte proliferation and cytotoxicity.